Subscribe to read this content
Subscribe now
Subscribe to read this content
Subscribe nowComunicare strengthens patient autonomy, therapeutic adherence and self-efficacy. Intelligent algorithms are used to provide personalized information about the pathology and its therapy; intelligent notifications allow patients to report their feelings (physiological parameters, symptoms, quality of life questions), manually or by means of validated medical devices.
Read more...For 18 months Comunicare worked with the oncology team of the CHU Liege. They set up patient/healthcare professional workshops. They also worked with the Wallonia eHealth Living Lab (WeLL) and wanted to set up a platform and an application that integrates the electronic health record. This platform integrates the patient, the general practitioner, the hospital and the nurse coordinators of the patient's journey are the cornerstone of the project.
The app was originally created for breast cancer. The company then expanded the possibilities to other pathologies: upper aerodigestive tract, ENT, multiple myeloma (hematology), heart failure, complex hypertension, COPD.
Read more...The hospital pays an annual license. Comunicare counts on benevolence that funds projects and sponsors who finance the provision of the app in different cases on a voluntary basis and without return or maybe in the case of studies.
It is free for the patient. He/she can use his or her own device (smartphone, tablet).
Comunicare’s first strategic partnership was with Solidaris (Belgian socialist mutuality) which financed part of the developments. On its website, Comunicare announces a new partnership with Ethias, a Belgian insurance company. They are making analyses and see the interest of patients in this type of tool. They want to finance the app for the patients.
Read more...We studied the use of Comunicare through an interview with Dr. Marc Tomas, a cardiologist who works in a medical center with 15 other doctors and paramedics. The medical house is not linked to a university or research center. Dr. Marc Tomas was a professor at the University of Namur.
Read more...